Artificially intelligent combat medical assistant

Tietronix Software Inc., a minority-owned small disadvantaged business based in Houston, Texas, was awarded $520,993.00 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Artificially Intelligent Combat Medical Assistant." The award, effective September 1, 2025, through August 31, 2027, funds the development of an artificial intelligence-enabled medical assistant designed to enhance healthcare delivery for military service members in combat environments. This initiative aligns with the DHA's strategic focus on transforming military healthcare through innovative and impactful biomedical research solutions.

Under this two-year project grant, Tietronix will develop software and engineering solutions that leverage advanced artificial intelligence technologies to support combat medical operations. The project builds on the company's established expertise in intelligent medical systems and advanced software development, areas in which it has previously delivered solutions including an Intelligent Medical Crew Assistant (IMCA) and augmented reality clinical interfaces. The award supports hypothesis-driven research and product development activities within the DHA's broader portfolio of basic, applied, and advanced medical research initiatives aimed at addressing critical health challenges specific to military personnel and advancing the state of battlefield medical care.